The Study
Impact of walnut consumption on cardio metabolic and anthropometric parameters in metabolic syndrome patients: GRADE-assessed systematic review and dose-response meta-analysis of data from randomized controlled trials.
This study combines results from several good-quality experiments where people were randomly given walnuts or not. It shows that eating walnuts probably helps lower one type of fat in the blood (triglycerides) in people with metabolic syndrome, but doesn’t seem to change other things like weight or blood sugar much.
Analysis score
Maximum 100 for a systematic review with meta-analysis.
Where the score came from
Scientists looked at eight studies where people with metabolic syndrome ate walnuts to see if it helped their health. They checked things like cholesterol, blood sugar, and weight.
Where does this study sit?
Systematic Reviews & Meta-analyses
Max 100Randomized Trials
Max 90Cohort Studies
Max 72Case-Control
Max 58Cross-Sectional
Max 44Case Reports & Series
Max 30Expert Opinion
Max 547 / 100
Quality score
The highest quality evidence. These studies systematically search, appraise, and synthesize results from multiple individual studies, providing the most reliable summary of current knowledge.
Key takeaways
Summary
Based on the study abstract and findings.
- 1Lowering triglycerides can help heart health, but since other numbers didn’t change, the overall benefit might be small.
- 2Walnuts lowered triglycerides by 0.1 mmol/L.
- 3No changes were seen in cholesterol, blood sugar, weight, or blood pressure.
- 4But the more walnuts people ate, the better their blood sugar and good cholesterol got.
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
Pharmacological research
Year
2022
Authors
Seyyed Mostafa Arabi, Leila Sadat Bahrami, Narges Milkarizi, M. Nematy, V. Kalmykov, A. Sahebkar
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.